IRUXOL MONO Collagenase Ointment 1.2U - Smith+Nephew
IRUXOL MONO Ointment is an enzyme-based product that acts selectively on collagen, freeing the wound of necrotic material so that healing can progress. Its active component, collagenase, helps break down native collagen in the wound and has been shown to remove of necrotic tissue from the wound bed. 1-3. Selective: Acts selectively on collagen 2.
UXOL® Mono ointment contains clostridiopeptidase (a collagenase enzyme) and protease enzymes. Each gram of ointment contains not less than 1.2 units of Cl. stridiopeptidase A and not less than 0.24 units of associated proteases as active ingredients. These enzymes can be …
IRUXOL® MONO Ointment is indicated for the enzymatic debridement of necrotising wounds. Its active component, collagenase, helps break down native collagen in the wound. Iruxol MONO has been shown to provide removal of necrotic tissue from the wound bed1.
Iruxol Mono 1.2U/g | myHealthbox
2018年4月13日 · Active ingredient: Clostridiopeptidase a; Protease. Available from: T.J. Smith & Nephew. ATC code: D03BA; D03BA52. INN (International Name): Clostridiopeptidase a; Protease. Dosage: 1.2 unit (s)/gram. Pharmaceutical form: Ointment. Prescription type: Product subject to prescription which may be renewed (B) Therapeutic area:
IRUXOL MONO - myHealthbox
2012年10月2日 · Composition IRUXOL ® mono is an enzyme preparation of Clostridium histolyticum containing the collagenase clostridiopeptidase A (EC 3.4.24.3) as the active constituent and other proteases as associated enzymes. 1 g of ointment contains not less than 1.2 units of clostridiopeptidase A and at least 0.24 units of its associated proteases in a ...
Drug Office | 藥 物 辦 公 室
2024年11月8日 · IRUXOL MONO OINTMENT Registration No.: HK-42514 Certificate Holder: SMITH & NEPHEW LTD Certificate Holder Address: UNIT 813-816 8/F DELTA HOUSE, 3 ON YIU ST SHATIN N.T. ... Ingredients: Active Ingredient; collagenase: Date …
IRUXOL NEO - Drug - RxReasoner
Active ingredients. The drug IRUXOL NEO contains a combination of these active pharmaceutical ingredients (APIs): 1 Clostridiopeptidase. UNII 9X7O8V25IT - COLLAGENASE CLOSTRIDIUM HISTOLYTICUM. Collagenases are proteinases that hydrolyze …
IRUXOL MONO - Drug - RxReasoner
Active ingredients. The drug IRUXOL MONO contains a combination of these active pharmaceutical ingredients (APIs): Collagenases are proteinases that hydrolyze collagen under physiological conditions. Collagenase clostridium histolyticum is comprised of a mixture of Class I (AUX-I) and Class II (AUX-II) clostridial collagenases in a defined mass ...
IRUXOL® MONO - myHealthbox
Iruxol. ®. mono ointment produces a gentle, bloodless and practically pain-free enzymatic debridement of wounds. Sloughs are dissolved or separated, thereby facilitating their removal. INDICATIONS. For wound cleaning in various types of ulcerations and decubitus; in poorly healing wounds and necroses. CONTRA-INDICATIONS.
Iruxol Ointment For The Enzymatic Wounds And Burn Debridement
2022年8月31日 · Iruxol Ointment is indicated for: the enzymatic debridement of necrotizing wounds, including leg and decubital ulcers. In ulcerations & necroses, such as leg ulcer, decumbitus, gangrene of the extremities, especially diabetic gangrene, frostbite. in poorly healing wounds i.e in wounds after operations, radiotherapy, accidents.